MREO

Mereo BioPharma Group PLC ADR (MREO)

US
$ 3.351.82%

Price Chart

Key Statistics

Market Cap
$ 364.11M
P/E Ratio
0.00
Revenue (TTM)
$ 1M
Volume
1.76M
52W High
$ 5.02
52W Low
$ 1.57
Dividend Yield
0.00%
Beta
0.47

Technicals

50-Day MA
2.3434
200-Day MA
3.3881
52 Week High
5.02
52 Week Low
1.575

About MREO

Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internati.

Employees
36
Headquarters
London, United Kingdom
CEO
Dr. Denise Vera Scots-Knight Ph.D.

Latest News

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg
SYTA
Siyata Mobile Inc. ...
$ 6.34
93.85
EYEN
Eyenovia Inc. Commo...
$ 1.83
61.95
EDBL
Edible Garden AG In...
$ 2.48
24.00
QBTS
D-Wave Quantum Inc....
$ 15.58
20.50
MLGO
MicroAlgo Inc. Ordi...
$ 1.59
17.78

Top Losers

Symbol/Name
LTP
% Chg
PTIX
Protagenic Therapeu...
$ 8.81
-20.63
ASPI
ASP Isotopes Inc. C...
$ 6.70
-11.02
BCLI
Brainstorm Cell The...
$ 1.25
-8.09
NWTN
NWTN Inc. Class B O...
$ 2.86
-6.54
TCOM
Trip.com Group Limi...
$ 63.01
-5.68